2024-10-18 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a leading pharmacy health care company that operates retail pharmacies, pharmacy benefit management, and health care services. 

**Performance Analysis:**

**1. Relative Performance:**

* CVS has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -30.44% compared to the S&P 500's 136.93%. This represents a divergence of -167.37%, which is a significant underperformance.
* **Current Relative Strength:** The current relative strength index (RSI) of 70.79 indicates that CVS is in overbought territory. 
* **PPO:** The PPO of 0.25 suggests a bullish momentum in the short term. 
* **Delta_Previous_Relative_Divergence:** The negative value of -1.13 indicates a recent short-term decline in the relative strength of CVS compared to the market.
* **Expected Return:** The expected return is 0.0% for the next 5 years. This indicates that CVS is not expected to outperform the S&P 500 in the future.

**2. Recent Price Movement:**

* **Closing Price:** $65.02
* **5-day Moving Average:** $66.23
* **20-day Moving Average:** $62.66
* **60-day Moving Average:** $59.65

CVS is currently trading above all three moving averages, suggesting an upward trend in price.

**3. Technical Analysis:**

* **RSI:** The RSI of 70.79 suggests that the stock is currently overbought. 
* **PPO:** The positive PPO of 0.25 indicates bullish momentum in the short term.
* **Delta_Previous_Relative_Divergence:** The negative value of -1.13 suggests that CVS is currently underperforming the market on a short-term basis.
* **Expected Return:** The expected return of 0.0% suggests that CVS is not expected to outperform the market in the future.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings for the quarter ending August 7, 2024, beat analysts' expectations by $0.10. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** CVS stock has recently experienced volatility due to concerns about the overall market and its competitive landscape. 
* **Analyst Opinions:** Many analysts remain cautiously optimistic about CVS's long-term potential but are concerned about short-term headwinds, such as inflation and rising healthcare costs.
* **Performance Highlights:** CVS has been focusing on expanding its healthcare services and leveraging its digital platforms to attract customers.  However, the company is facing pressure from competition and increased scrutiny from regulators. 

**6. Comprehensive Analysis:**

CVS Health Corp is a company with significant market share in the pharmacy and healthcare sector. However, the stock has been facing significant challenges in recent years due to competition, regulatory scrutiny, and economic uncertainty. While the company has taken steps to address these issues, it remains to be seen if they will be enough to drive meaningful long-term growth. The current technical indicators suggest that the stock is overbought and may be poised for a short-term correction. 

**7. Recommendation:**

Based on the current analysis, CVS Health Corp appears to be a high-risk, high-reward investment opportunity. Investors should carefully consider their risk tolerance and investment goals before making any investment decisions. 

**Disclaimer:** This report is for informational purposes only and does not constitute investment advice. Always consult with a financial professional before making any investment decisions.